Importantly, the depletion of CD4+ T cells before tumor inoculation compromised vaccine efficacy in both 3LL and TC-1 tumor models, while depletion one day before vaccination in mice with established tumors had no significant effect on the therapeutic efficacy of the vaccines. This evidence concerns the gene CD4 and neoplasm.